Evogene Ltd.
Evogene Ltd. (Nasdaq, TASE: EVGN) is a pioneering computational chemistry company developing generative AI to design and optimize small molecules for the pharmaceutical and agricultural industries.
Latest Press Releases
Press releases
09.03.2026
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
Press releases
05.03.2026
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
Webcast registration
Webcast
Thu, March 5, 2026 | 9:00 am
Q4 and Full Year 2025 Financial Results Call
The Company’s management will host a Zoom conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time.
To join the conference, please register in advance.
Presentations
Evogene Company Presentation
12.03.2026
Latest Financial Results
Q4 EARNINGS CALLS
Earnings Call Presentation
05.03.2026
Financial Results
05.03.2026
Sign Up for Investor Relations Email Alerts
Investor Relations Contact